News
Bristol-Myers Squibb Company (NYSE:BMY) is one of the top low volatility healthcare stocks to buy now. On July 24, Goldman ...
ReAlta Life Sciences, Inc. ("ReAlta" or the "Company"), a clinical-stage biopharmaceutical company dedicated to saving lives ...
Acknowledging the limits of disease-modifying drugs like Leqembi and Kisunla, companies like Bristol Myers Squibb, Acadia, ...
1h
24/7 Wall St. on MSN4 High-Yield Blue-Chip Pharmaceutical Giants Offer Huge Total Return PotentialHere are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.
ReAlta Life Sciences Inc., a clinical-stage biopharmaceutical company, has appointed Ellen Lubman, MBA as Chief Business ...
These five upcoming data drops could usher in more effective and convenient therapies for Alzheimer’s disease and open up ...
Atai Life Sciences’ schizophrenia drug has failed to improve cognition in a phase 2 study, leading the biotech to reaffirm ...
Coming up: a key tariffs deadline, the Fed’s interest-rate decision, the July jobs report, fresh inflation data, and earnings ...
Tesla rises after President Donald Trump says he struck a deal to set 15% tariffs on goods from the European Union, including automobiles.
First-line treatment with the monoclonal antibody is associated with more patients achieving robust clinical response at 3 months vs standard of care, but by 6 months no advantage remained.
In an exclusive interview with Business Today, D. Sridhar Babu, Minister for Information Technology, Industries and Commerce, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results